I. Casolaro
University of Siena
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by I. Casolaro.
Journal of Affective Disorders | 2016
Arianna Goracci; Paola Rucci; R. N. Forgione; G. Campinoti; Marta Valdagno; I. Casolaro; Elisa Carretta; S. Bolognesi; Andrea Fagiolini
BACKGROUND Research evidence on the effects of integrated multifaceted lifestyle interventions for depression is scanty. The aim of the present study is to report on the development, acceptability and efficacy of a standardized healthy lifestyle intervention, including exercise, eating habits, sleep hygiene and smoking cessation in preventing relapses. METHODS One hundred-sixty outpatients with recurrent unipolar depression or bipolar disorder were recruited after achieving full remission or recovery from the most recent depressive episode. Patients were randomized to 3-months of usual care or to an intervention aimed at promoting a healthy lifestyle (HLI), as an augmentation of pharmacological maintenance treatment. Usual care consisted of clinical management visits. At the end of the intervention, follow-up visits were scheduled at 3,6,9 and 12 months. RESULTS During the intervention phase, 1 relapse occurred in the HLI group and 4 in the control group. Over the 12 months of follow-up, relapses were 5 in the HLI group and 16 in control group. Using an intent-to-treat approach, the overall percentage of relapses was 6/81 (7.4%) in the HLI group vs. 20/79 (25.3%) in the control group.. In a Kaplan-Meier survival analysis the risk of relapse was significantly lower in patients receiving the HLI intervention (log-rank test, p=0.003) over the 60 weeks of observation. The majority of patients assigned to HLI adhered to the program, and were highly motivated throughout the intervention. LIMITATIONS The retention rate was low because patients were recruited during the maintenance phase and the 1-year follow-up was relatively short to detect a long-term effect of HLI. CONCLUSIONS The HLI program proved to be efficacious in preventing relapses. Given the absence of contraindications and its cost-effectiveness in routine practice, the use of HLI should be encouraged to promote the well-being of patients with recurrent depression.
Rivista Di Psichiatria | 2012
Letizia Bossini; I. Casolaro; Emiliano Santarnecchi; C. Caterini; Despina Koukouna; Isabel Fernandez; Andrea Fagiolini
UNLABELLED Strong evidences support use of EMDR in patients suffering from post-traumatic stress disorder (PTSD). AIM To evaluate clinical and neurobiological-structural efficacy of EMDR on drug-naïve PTSD without comorbidity. MATERIALS AND METHODS We made clinical evaluation and hippocampal volume measurement by MRI on 29 subjects suffering from PTSD and on 30 healthy control-subjects. Then, patients were treated with EMDR and after three months of psychotherapy the clinical evaluation and the MRI exam were replied. RESULTS AND DISCUSSION Our results demonstrated that the diagnosis of PTSD was no more possible on all the patients who terminated the psychotherapy (n=18). At the same time, all the patients showed an average increase of 6% in hippocampal volumes. CONCLUSIONS Our reaserach suggests that EMDR treatment correlates not only with a significant improvement of symptoms of PTSD, but also with a significant increase of hippocampal volumes.
Psychiatria Polska | 2016
Letizia Bossini; I. Casolaro; D. Koukouna; C. Caterini; Miriam Olivola; Andrea Fagiolini
OBJECTIVES To identify possible differences, in terms of duration and severity of Post-Traumatic Stress Disorder, between victims of terrorist attacks and subjects who underwent other types of traumatic events. METHODS A sample of subjects suffering from PTSD was selected. After a clinical interview aimed at the collection of anamnestic data, CAPS to confirm the diagnosis of PTSD and DTS to assess frequency and severity of post-traumatic symptoms were administered. One-way ANOVA was used in order to compare the differences in the parameters analysed through the DTS scales and its clusters between the victims of terrorist attacks and patients undergone other traumatic events. RESULTS The duration of PTSD was 258 +/ - 144.9 months for people who underwent a terrorist attack and 41.6 +/ - 11.8 months for victims of other traumatic events. As regards the severity of the disorder, the total score of the DTS scale was 65.6 +/ - 26.9 in victims of terrorist attacks and 78.2 +/ - 28.2 in people who undergone other traumatic events. However, the difference was not statistically significant; Avoidance and Hypervigilance clusters showed an important statistical significance. CONCLUSIONS No significant differences are present in terms of severity, showing that PTSD is a disabling disorder regardless the type of event that triggers it; however, a significant difference in terms of duration of the disorder leads to reflec on the importance of an early diagnostic process aimed toward the victims of terrorism, in order to avoid the risk of chronicity and progression to other psychiatric disorders such as depression.
Expert Opinion on Pharmacotherapy | 2012
Letizia Bossini; I. Casolaro; D. Koukouna; Federica Cecchini; Andrea Fagiolini
Current Pharmaceutical Design | 2015
Letizia Bossini; Anna Coluccia; I. Casolaro; Jim Benbow; Giovanni Amodeo; Riccardo De Giorgi; Andrea Fagiolini
Psychiatria Polska | 2014
Letizia Bossini; Fortini; I. Casolaro; C. Caterini; D. Koukouna; Federica Cecchini; Jim Benbow; Andrea Fagiolini
Rivista Di Psichiatria | 2017
Letizia Bossini; Emiliano Santarnecchi; I. Casolaro; D. Koukouna; C. Caterini; Federica Cecchini; Valentina Fortini; Giampaolo Vatti; Daniela Marino; Isabel Fernandez; Alessandro Rossi; Andrea Fagiolini
Psychiatria Polska | 2013
Letizia Bossini; I. Casolaro; C. Caterini; D. Koukouna; Fortini; Federica Cecchini; Andrea Fagiolini
European Neuropsychopharmacology | 2016
L. Sabbioni; Letizia Bossini; I. Casolaro; L. Del Matto; Andrea Fagiolini
European Neuropsychopharmacology | 2016
D. Koukouna; Letizia Bossini; I. Casolaro; C. Caterini; Andrea Fagiolini